References
- 1. Gupta R, Espinal MA, Raviglione MC. Tuberculosis as a major global health problem in the 21st century: a WHO perspective. Semin Respir Crit Care Med. 2004;25(3):245-53.
- 2. WHO: Global tuberculosis report 2012. http://www.who.int/tb/data.
- 3. Victor TC, van Helden PD, Warren R. Prediction of drug resistance in M. tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life. 2002;53(4-5):231-7.
- 4. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998;79(1):3-29.
- 5. Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Allele-specific rpoB PCR assays for detection of rifampinresistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother. 2003;47(7):2231-5.
- 6. Parsons LM, Somoskövi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.
- J Clin Microbiol Rev. 2011;24(2):314-50.
- 7. Palomino JC. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol. 2009;56(2):103-11.
- 8. Gillespie SH. Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective. Antimicrob Agents Chemother. 2002; 46(2): 267-74.
- 9. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993;341(8846):647-50.
- 10. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol. 2002;40(12):4435-8.
- 11. G. Canetti, S. Froman, J. Grosset, P. Hauduroy. Mycobacteria: Laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ. 1963;29:565-8.
- 12. G. Canetti, W. Fox, A. Khomenko, H.T. Mahler, N.K. Menon, D.A. Mitchison et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41:21-43.
- 13. Kim SJ. Drug-susceptibility testing in tuberculosis: Methods and reliability of results. Eur Respir J. 2005;25:564-9.
- 14. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evalua- tion of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol. 2006;44(7):2338-42.
- 15. Vitoria M, Granich R, Gilks CF, Gunneberg C, Hosseini M, Were Wetal. The Global Fight Against HIV/AIDS, Tuberculosis, and Malaria Current Status and Future Perspectives. Am J Clin Pathol.2009;131:844-8.
- 16. Ghid Metodologic De Implementare A Programului Naţional De Control Al Tuberculozei 2007-2011, Institutul Naţional De Pneumologie “Marius Nasta” Bucureşti, 2007, http://www.srp.ro/Programul-Nationalde-Control-al-Tuberculozei-118.htm
- 17. Mokrousov I, Filliol I, Legrand E, Sola C, Otten T, Vyshnevskaya E et al. Molecular characterization of multiple- drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. Res Microbiol. 2002;153(4):213-9.
- 18. Generozov EV, Akopian TA, Govorun VM, Chernousova LN, Larionova EE, Savinkova SN et al. Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia. Mol Gen Mikrobiol Virusol. 2000;(1):11-7. Russian
- 19. Nikolayevsky V, Brown T, Balabanova Y, Ruddy M, Fedorin I, Drobniewski F. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol. 2004;42(10):4498-502.
- 20. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol. 2002;40(6):1930-7.
- 21. Huang WL, Chen HY, Kuo YM, Jou R. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2009;47(8):2520-4.
- 22. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177(7):787-92.
- 23. Hristea A, Otelea D, Paraschiv S, Macri A, Baicus C, Moldovan O et al. Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by realtime PCR. Indian J Med Microbiol. 2010;28:211-6.
- 24. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol. 2006;44(7):2485-91.
- 25. Valcheva V, Mokrousov I, Narvskaya O, Rastogi N, Markova N. Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria. Infect Genet Evol. 2008;8:657-63.
- 26. Dymova MA, Liashenko OO, Poteiko PI, Krutko VS, Khrapov EA, Filipenko ML. Genetic variation of Mycobacterium tuberculosis circulating in Kharkiv Oblast, Ukraine. BMC Infect Dis. 2011;11:77.
- 27. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2005;43(8):3699-703.
- 28. Bártfai Z, Somoskövi A, Ködmön C, Szabó N, Puskás E, Kosztolányi L et al. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol. 2001;39(10):3736-9.
- 29. Crudu V, Stratan E, Romancenco E, Allerheiligen V, Hillemann A, Moraru N. First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J Clin Microbiol. 2012;50(4):1264-9.
- 30. Rosales-Klintz S, Jureen P, Zalutskayae A, Skrahina A, Xu B, Yi Hu Y et al. Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions. Int J Mycobacteriol. 2012;1(3):124-30.